-
Ulotaront (INNTooltip
International Nonproprietary Name;
developmental codes SEP-363856, SEP-856) is an
investigational antipsychotic that is undergoing...
-
developed by Hoffmann-La Roche.
Ralmitaront (RG-7906; RO-6889450) RG-7410
Ulotaront (SEP-363856; SEP-856) "RG 7351". AdisInsight.
Springer Nature Switzerland...
-
completed by
October 2014.
Ralmitaront (RG-7906; RO-6889450) RG-7351
Ulotaront (SEP-363856; SEP-856) "RG 7410". AdisInsight. 13
October 2015. Retrieved...
- o-PIT
Propylhexedrine Ralmitaront (RG-7906, RO-6889450) RG-7351 RG-7410 RO-5166017 RO-5256390 RO-5263397
Selegiline Solriamfetol Ulotaront (SEP-363856)...
- July 2023.
Retrieved 9
November 2023.
Ulotaront failed to meet
primary endpoints in two studies. [...]
Ulotaront is also in
Phase II/III
clinical studies...
- mechanisms, ligands, and
physiological functions of
these receptors.
Ulotaront / SEP 363856 is a TAAR1
agonist in
phase 3
clinical trials for schizophrenia...
- List of
investigational antipsychotics §
Monoamine receptor modulators Ulotaront "Ralmitaront - Roche". AdisInsight.
Springer Nature Switzerland AG. Gomes...
- to form
Sumitomo Pharma America, Inc. (SMPA),
effective July 1, 2023.
Ulotaront (SEP-856) –
phase III Aramisulpride:esamisulpride (85:15 ratio) (SEP-4199)...
- o-PIT
Propylhexedrine Ralmitaront (RG-7906, RO-6889450) RG-7351 RG-7410 RO-5166017 RO-5256390 RO-5263397
Selegiline Solriamfetol Ulotaront (SEP-363856)...
-
version of amisulpride)
Ralmitaront (RG-7906, RO-6889450) – TAAR1
agonist Ulotaront (SEP-856, SEP-363856) – 5-HT1A
receptor and TAAR1
agonist Usmarapride...
